SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Annual Wellness Visit, Subsequent — Frederick Law Olmsted

PatientFrederick Law Olmsted
Date of birth1953-04-26
IdentifiersMRN HR-NI022-SYN; SSN (made up) 000-22-5519
Document date2026-09-15
AuthorNathan Calder, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Olmsted is a 73-year-old man with mild dementia of undetermined type who returns with his caregiver for his subsequent annual wellness visit, six weeks after his three-month dementia review. He answered the health risk assessment himself, with his caregiver reading the questions and adding what he could not recall. His cold in July cleared in two weeks, and he has had no further night-time confusion since the antihistamine was stopped. He takes donepezil 10 mg each morning, given by his caregiver from a weekly organizer, with no nausea, diarrhea, dizziness, or vivid dreams. He no longer drives. He walks most days with company and goes to an adult day program twice a week, which he enjoys for the gardens. He has had no falls, emergency visits, or hospital stays this year. [S]

ElementDetail
VisitSubsequent annual wellness visit
ContextHealth risk assessment answered by the patient with caregiver help because of dementia
Safety eventsNo falls, emergency visits, or hospital stays this year
MedicinesDonepezil 10 mg daily from a weekly organizer; no over-the-counter medicines since the cold
Active conditionsMild dementia of undetermined type, CDR 1
Functional statusIndependent in basic activities of daily living; needs help with finances, medicines, and travel

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
How completedAnswered by the patient with his caregiver reading the questions and adding what he could not recall
Self-rated healthGood, in his words
PsychosocialLives at home with family; adult day program twice a week; misses his work but enjoys the gardens and visitors
TobaccoNever used tobacco
AlcoholNone since the first visit (AUDIT-C 0)
Physical activityWalks 30 to 45 minutes most days with company
NutritionThree regular meals; weight stable over the past three months
SleepSleeps through most nights; no sleep medicines
Activities of daily livingIndependent in bathing, dressing, toileting, and eating
Instrumental activities of daily livingCaregiver manages medicines, bill paying, and transport, with his agreement
Home safetyNo firearms in the home; medicines kept locked; night lights in place; smoke detectors working
FallsNo falls this year
Hearing and visionNo hearing concern; reading glasses; no eye examination in the past two years
MemoryKnown mild dementia; his caregiver notices no change since the spring

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable over three months; no fever or new fatigue
EyesNegativeNo change in vision with reading glasses
Ears, nose, mouth, and throatNegativeCold resolved; no hearing difficulty in conversation
CardiovascularNegativeNo chest pain, fainting, or lightheadedness on donepezil
RespiratoryNegativeCough resolved; no breathlessness
GastrointestinalNegativeNo nausea, diarrhea, or loss of appetite on donepezil
GenitourinaryNegativeGets up once a night to pass urine; no incontinence
MusculoskeletalNegativeNo joint pain or falls
IntegumentaryNegativeNo new or changing skin lesions
NeurologicalPositiveKnown memory loss, unchanged by his caregiver's account; no night-time confusion since the antihistamine was stopped
PsychiatricNegativeMood fair to good; no hallucinations or agitation; PHQ-2 score 1
EndocrineNegativeNo thirst or frequent urination

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Donepezil 5 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route2026-06-02 to 2026-08-04completedS
Donepezil 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route2026-08-04activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-15Body height175cmS
2026-09-15Body weight71kgS
2026-09-15Body mass index (BMI) [Ratio]23.2kg/m2S
2026-09-15Systolic blood pressure128mm[Hg]S
2026-09-15Diastolic blood pressure74mm[Hg]S
2026-09-15Heart rate60/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-09-15Total score [AUDIT-C]0{score}S
2026-09-15Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=200 mg/dLNormalS
2026-09-15Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=40 mg/dLNormalS
2026-09-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=129 mg/dLNormalS
2026-09-15Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-09-15; see the Vital Signs section. [S]

SystemFinding
ConstitutionalAlert, courteous, and well groomed; weight 71.0 kg, BMI 23.2
EyesPupils equal and reactive; near vision 20/30 with reading glasses
EarsCanals clear; whispered-voice test passed in both ears
NeckNo thyroid enlargement or nodes; no carotid bruits
CardiovascularRegular rhythm at 60 per minute; no murmur; no edema; blood pressure 128/74 mmHg
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no masses or aortic pulsation
MusculoskeletalTimed Up and Go 11 seconds; rises from a chair without using his arms
NeurologicalOriented to person and place, not to date; repeats a question once; no focal weakness; normal gait. Cognition assessed by direct observation and the established diagnosis
PsychiatricPleasant and engaged; no agitation
SkinWeathered skin on the face and hands; no suspicious lesions

Problems

ProblemClinical statusVerificationCodeProvenance
Mild dementia (major neurocognitive disorder), progressive, amnestic-predominant with executive difficulty, type undetermined; CDR global 1activeconfirmed F03.A0S — Synthetic modern coding of his documented failing memory; the cause is unknown, so the type is left unspecified. Stage and scores are synthetic.
Common cold, with two nights of increased confusion after an over-the-counter nighttime cold medicine containing diphenhydramine; resolvedresolvedconfirmed J00S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.
Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairmentresolvedconfirmed R41.3S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D).

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, this seasonCompleted todayHigh-dose vaccine given today
Pneumococcal vaccineCompleted todayPCV20 given today; no further doses needed
Recombinant zoster vaccineCompleted todayDose 1 given today; dose 2 due in two to six months
COVID-19 vaccine, this seasonDueRecommended at his age; his caregiver will arrange it at the pharmacy
RSV vaccineNot indicatedRecommended at 75 and older, and from 50 with conditions that raise risk; he has none. Review at 75
Tetanus, diphtheria, and pertussis boosterDueNo dose on record in the past ten years; to be given with the second zoster dose
Depression screeningCompleted todayPHQ-2 score 1; PHQ-9 continues at the dementia reviews
Alcohol misuse screeningCompleted todayAUDIT-C score 0
Cognitive assessmentCompleted todayDirect observation in established mild dementia; MoCA 19 at diagnosis, repeated yearly on the CMID schedule
Falls preventionCompleted todayTimed Up and Go 11 seconds; no falls; daily walking continues
HearingCompleted todayWhispered-voice test passed in both ears; hearing loss would worsen cognition, so it will be rechecked yearly
Eye examinationDueNo eye examination in the past two years; his caregiver will book one
Cholesterol screening and statin decisionCompleted todayTotal cholesterol 196, HDL 54, LDL 118, triglycerides 120 mg/dL. Ten-year risk about 18 percent from age alone, without diabetes, hypertension, dyslipidemia, or smoking, so the USPSTF criteria for a statin are not met. A statin was discussed; he prefers no new daily medicine, and his caregiver agrees
Diabetes screeningNot indicatedRecommended for overweight adults 35 to 70; BMI 23.2, and glucose was normal in May
Colorectal cancer screeningOrderedNo screening on record in the past ten years; at 73 with mild dementia and good health, he chose a fecal immunochemical test, and a kit was given to his caregiver today
Prostate cancer screeningNot indicatedPSA screening is not recommended at 70 and older
Hepatitis C screeningOrderedOne-time screening recommended for adults 18 to 79; no result on record; drawn with today's blood tests with his consent
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Advance care planningUp to dateHealth care agent named and his wishes recorded six weeks ago; reviewed today without change

Immunizations given today: High-dose influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Six-month dementia review in about six weeks. Second zoster dose and the Tdap booster in two to six months. Return the stool test kit within two weeks; the hepatitis C result will be sent by letter. Next annual wellness visit in one year. Next scheduled visit 2026-10-27: six-month dementia review. [S]

Advance Care Planning

The advance care planning completed six weeks ago was reviewed with him and his caregiver. His health care agent remains the same and is recorded in the chart, not named here. He confirmed that what matters most to him is staying at home among gardens and trees for as long as it is safe, and being told the truth about his condition. No decisions were changed. The plan will be revisited at the yearly dementia review and at any change in stage. [S]